KUBE MEDICAL LIMITED

Registered Number
06706073
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

Company Information
for the year from 1 April 2024 to 31 March 2025


Directors	CAMPBELL, Patrick
	CAMPBELL, Samantha Ruth, Dr


Registered Address	Nexus Business Centre Darby Close
	Cheney Manor Industrial Estate
	Swindon
	SN2 2PN


Registered Number	06706073 (England and Wales)

KUBE MEDICAL LIMITED

Balance Sheet as at
31 March 2025

	Notes	2025		2024
		£	£	£	£
Fixed assets
Tangible assets	3		13,499		13,551
			13,499		13,551
Current assets
Stocks		1,065		2,594
Debtors		94,632		17,444
Cash at bank and on hand		46,730		64,433
		142,427		84,471
Creditors amounts falling due within one year		(109,683)		(40,199)
Net current assets (liabilities)			32,744		44,272
Total assets less current liabilities			46,243		57,823
Creditors amounts falling due after one year			(930)		(21,667)
Net assets			45,313		36,156
Capital and reserves
Called up share capital			2		2
Profit and loss account			45,311		36,154
Shareholders' funds			45,313		36,156

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Board of Directors on 26 June 2025, and are signed on its behalf by:

CAMPBELL, Samantha Ruth, Dr
Director
Registered Company No. 06706073

KUBE MEDICAL LIMITED

Notes to the Financial Statements
for the year ended 31 March 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

	Revenue from sale of goods
	Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

Revenue from sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Employee benefits
	Contributions to defined contribution plans are expensed in the period to which they relate.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Tangible fixed assets and depreciation
	Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

	Stocks and work in progress
	Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).

2.	Average number of employees


		2025		2024
	Average number of employees during the year	12		9

3.	Tangible fixed assets

		Total
		£
	Cost or valuation
	At 01 April 24	29,377
	Additions	2,331
	At 31 March 25	31,708
	Depreciation and impairment
	At 01 April 24	15,826
	Charge for year	2,383
	At 31 March 25	18,209
	Net book value
	At 31 March 25	13,499
	At 31 March 24	13,551